Correspondence to Charlotte Mary Duffee, Institute for the History and Philosophy of Science and Technology, University of Toronto, Toronto, ON M5S 1K7, Canada; ...
Digital twins or AI SIMs? What to call generative AI systems designed to emulate specific individuals, in healthcare settings and beyond ...
Prominent consequentialists who write about conscientious objection (CO) in healthcare, Julian Savulescu and Udo Schüklenk, both argue for the ‘incompatibility thesis’—the view that healthcare ...
In his article ‘Bioethics and the value of disagreement’1 Michael J. Parker proposes ‘adversarial cooperation’ as a new model for bioethics. Inspired by the practice of adversarial collaboration in ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
Michael Parker’s novel recommendation1 for bioethicists to embrace adversarial cooperation (AC) to address deep value disagreements is both welcome and refreshing. However, the prerequisites for the ...
Dr Marcus Teo states that my claim that prospective parents have a moral obligation to have genetically related children is invalid because I have ignored the non-identity problem. He maintains that ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
Patient organisations aim to advance the interests of patient populations living with various diseases, disabilities and health conditions. However, because the members of a given patient population ...
Background: In Switzerland, non-medical right-to-die organisations such as Exit Deutsche Schweiz and Dignitas offer suicide assistance to members suffering from incurable diseases. Objectives: First, ...
On 1 May 2004 research ethics committees became legally accountable to a new government body, the United Kingdom Ethics Committee Authority. This marks the end of the self regulation of research ...
Ryan and Savulescu recently offered an ethical analysis of the use of semaglutide-based weight-loss drugs such as Ozempic. In this response, we continue the discussion and argue that their framework ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback